Richard Quinn is a freelance writer in New Jersey.
Reference
ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
- Weinblatt ME, Baranauskaite A, Niebrzydowski J, et al. A phase 3, randomized, double-blind clinical study comparing SB5, an adalimumab biosimilar, with adalimumab reference product (humira) in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy (24-week results). Arthritis Rheumatol. 2015 Oct;67(s10): 1–4046. doi: 10.1002/art.39448.